Schering-Plough in US$14.4 B Acquisition of Organon BioSciences
Business Review Editor
Abstract
Schering-Plough acquired Organon BioSciences for approximately €11 B (US$14.4 B). Organon BioSciences is the human and animal healthcare unit of Akzo-Nobel.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.